Lv2
110 积分 2024-03-25 加入
Pathophysiology and prevalence of high output heart failure in group 1 pulmonary hypertension
3个月前
已完结
Growth Differentiation Factor-15 Improves Prognostic Accuracy of Risk Stratification in Pulmonary Arterial Hypertension
5个月前
已完结
GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma
5个月前
已完结
Heart Rate Response Predicts 6-Minutes Walking Distance in Pulmonary Arterial Hypertension
6个月前
已完结
Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension
6个月前
已完结
The Inherited Basis of Coronary Artery Disease
7个月前
已关闭
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
9个月前
已完结
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
10个月前
已完结
Pulmonary Vascular Remodeling in Pulmonary Hypertension Mice Aggravated by Hypothyroidism
11个月前
已关闭
皖公网安备34019202002308
